Emerging evidence points to pro‐oncogenic roles for some FOXO factors in cancers such as diffuse large B‐cell lymphoma (DLBCL), in which FOXO1 is commonly mutated to a constitutively nuclear form; these FOXO1 mutations were associated with poor prognosis [25]. The gene discussed is FOXO1; the disease is diffuse large B-cell lymphoma.